Steris (STE) Misses Q3 EPS by 6c; Lowers Outlook
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $234.69 -0.81%
Financial Fact:
Interest expense: 7.49M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense: 7.49M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q3 EPS of $0.98, $0.06 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $646.8 million versus the consensus estimate of $679.14 million.
GUIDANCE:
Steris sees FY2017 EPS of $3.70-$3.76, versus the consensus of $3.89.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
